Mayne Pharma reported $226.66M in Operating Expenses for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Ansell ANN:AU $ 903.9M 110.8M
Australian Pharma API:AU $ 2.03B 75M
Cochlear COH:AU $ 623.7M 123.9M
CSL CSL:AU $ 3.8B 417M
Ecofibre Ltd EOF:AU 15.97M 6.13M
Healius Ltd HLS:AU $ 835M 24.7M
Integral Diagnostics Ltd IDX:AU 158.09M 19.33M
Nanosonics Ltd NAN:AU $ 49.17M 6.02M
Next Science Ltd NXS:AU 8.18M 478.3K
Polynovo Ltd PNV:AU 18.88M 4.37M
Probiotec Ltd PBP:AU 72.36M 31.92M
Ramsay Health Care RHC:AU $ 5.95B 552.9M
ResMed RMD:AU $ 634.47M 89.12M
Sigma Healthcare Ltd SIG:AU 1.79B 20.98M
Sonic Healthcare SHL:AU $ 3.4B 40.74M
Telix Pharmaceuticals Ltd TLX:AU 32.85M 1.5M